Page 35 - Teddy Whiley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Omega Diagnostics Gp, UK Government contract and trading update

    Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces the appointment of Dr Simon Douglas as independent Non-Executive Chairman. Simon has been appointed to the Board with immediate effect, after a thorough search process that was conducted with the help of Snedden Campbell Ltd. Simon has also become a member of both the Audit Committee and the Remuneration Committee.   Simon has 25 years of Board level experience at both early stage and public businesses within the Diagnostics, Life S...

ANGLE plc: Angle Plc - Announces Parsortix: Dynamic Assessment of Patient Response Use of Parsortix System Enables a Dynamic Assessment of Patient Response to Treatment in Non-Small Cell Lung Cancer CTCs harvested by the Parsortix system successfully used to measure the dynamic role of EMT and PD-L1 in patient response to therapy Findings support ANGLE's plan for the growth of a new "pharma services" business area using the Parsortix system as a biomarker for cancer drug trials allowing longitudinal monitoring of patients GUILDFORD, SURREY / ACCESSWIRE / February 8, 2021 / ANGLE plc (AIM:AGL...

CANCER-ID was a European consortium funded by the Innovative Medicines Initiative (IMI) aimed at the establishment of standard protocols for and clinical validation of blood-based biomarkers. It brought together experts from academic and clinical research, innovative Small-to-Medium sized Enterprises (SMEs), diagnostics companies and the pharmaceutical industry thus providing a unique setting for establishing clinical utility of "liquid biopsies".   About ANGLE plc www.angleplc.com   ANGLE is a world leading liquid biopsy company with sample-to-answe...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...